EUVIMEDEUVIMED entdecken
FallberichtMultizentrische StudieÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Efficacy and Safety of Ropeginterferon Alfa-2b in Pregnant Women With Myeloproliferative Neoplasms: Case Series of Three Subtypes and Review

Hangyeol Kim iD, Sung-Eun Lee iD, Young Rok Do iD, Sung-Yong Kim iD, Junshik Hong iD

Journal of Korean Medical Science · 2026

DOI: 10.3346/jkms.2026.41.e327 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Korean Medical Science, 2026. Verfasst von Hangyeol Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Polyethylene Glycols, Interferon-alpha, Myeloproliferative Disorders, Antineoplastic Agents. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Managing myeloproliferative neoplasms (MPNs) during pregnancy is challenging due to increased thrombotic risk and limited cytoreductive options. Ropeginterferon alfa-2b (ropeginterferon), a long-acting mono-pegylated interferon, has limited data in this setting. We report a Korean multicenter case series of four pregnancies across MPN subtypes, including prefibrotic/early primary myelofibrosis, essential thrombocythemia, and polycythemia vera. Ropeginterferon was used during pregnancy or prior to conception (250-500 μg every 2-12 weeks) with aspirin and/or low-molecular-weight heparin. Hematologic responses were sustained throughout pregnancy without treatment-limiting adverse events. All pregnancies resulted in live births without major maternal or neonatal complications. Within the limits of a small retrospective series, ropeginterferon appeared to be a feasible cytoreductive option in these MPN pregnancies, including pre-conception and intra-pregnancy use; these preliminary observations warrant confirmation in larger prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsInterferon-alphaMyeloproliferative DisordersAntineoplastic AgentsPregnancy Complications, NeoplasticHumansFemalePregnancyRecombinant ProteinsInterferon alpha-2AdultPolycythemia VeraThrombocythemia, EssentialPrimary MyelofibrosisHeparin, Low-Molecular-WeightAspirin

Stichwörter der Autor:innen

Myeloproliferative DisordersPolycythemia VeraPregnancyPrimary MyelofibrosisRopeginterferon Alfa-2bThrombocythemia, Essential

Substanzen

Recombinant ProteinsPolyethylene GlycolsInterferon alpha-2Interferon-alphapeginterferon alfa-2bHeparin, Low-Molecular-WeightAspirinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Division of Hemato-Oncology, Department of Medicine, Dongsan Medical Center, Keimyung University, Daegu, Korea.
  • Division of Hematology/Oncology, Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. hongjblood@snu.ac.kr.

ORCID-Profile: Hangyeol Kim, Sung-Eun Lee, Young Rok Do, Sung-Yong Kim, Junshik Hong

Zitieren

APA

Kim, H., Lee, S. E., Do, Y. R., Kim, S. Y., & Hong, J. (2026). Efficacy and Safety of Ropeginterferon Alfa-2b in Pregnant Women With Myeloproliferative Neoplasms: Case Series of Three Subtypes and Review. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2026.41.e327

Vancouver

Kim H, Lee SE, Do YR, Kim SY, Hong J. Efficacy and Safety of Ropeginterferon Alfa-2b in Pregnant Women With Myeloproliferative Neoplasms: Case Series of Three Subtypes and Review. Journal of Korean Medical Science. 2026. doi:10.3346/jkms.2026.41.e327

BibTeX
@article{Kim2026,
  author = {Kim, Hangyeol and Lee, Sung-Eun and Do, Young Rok and Kim, Sung-Yong and Hong, Junshik},
  title = {Efficacy and Safety of Ropeginterferon Alfa-2b in Pregnant Women With Myeloproliferative Neoplasms: Case Series of Three Subtypes and Review},
  journal = {Journal of Korean Medical Science},
  year = {2026},
  doi = {10.3346/jkms.2026.41.e327}
}
Kostenlos starten →